These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8772203)
1. Adverse events associated with ephedrine-containing products--Texas, December 1993-September 1995. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1996 Aug; 45(32):689-93. PubMed ID: 8772203 [TBL] [Abstract][Full Text] [Related]
2. From the Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products--Texas, December 1993-September 1995. JAMA; 1996 Dec; 276(21):1711-2. PubMed ID: 8940308 [No Abstract] [Full Text] [Related]
3. Are serious adverse cardiovascular events an unintended consequence of the Dietary Supplement Health and Education Act of 1994? Lindsay BD Mayo Clin Proc; 2002 Jan; 77(1):7-9. PubMed ID: 11795250 [No Abstract] [Full Text] [Related]
5. [Ephedrine and ephedra in weight loss products and other preparations]. van der Hooft CS; Stricker BH Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223 [TBL] [Abstract][Full Text] [Related]
8. Adverse events associated with ingestion of gamma-butyrolactone--Minnesota, New Mexico, and Texas, 1998-1999. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1999 Feb; 48(7):137-40. PubMed ID: 10077458 [TBL] [Abstract][Full Text] [Related]
9. Gamma hydroxy butyrate use--New York and Texas, 1995-1996. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(13):281-3. PubMed ID: 9121419 [TBL] [Abstract][Full Text] [Related]
10. A retrospective review of California poison control system data of sibutramine exposures. Minns AB; Ebrahimi S; Te L; Ly B; Clark RF; Cantrell FL Clin Toxicol (Phila); 2009 Sep; 47(8):814-7. PubMed ID: 19778191 [TBL] [Abstract][Full Text] [Related]
14. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule. Food and Drug Administration, HHS Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803 [TBL] [Abstract][Full Text] [Related]
15. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule. Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services J Pain Palliat Care Pharmacother; 2004; 18(3):95-107. PubMed ID: 15364637 [TBL] [Abstract][Full Text] [Related]
16. Follow-up study of pseudoephedrine users. Porta M; Jick H; Habakangas JA Ann Allergy; 1986 Nov; 57(5):340-2. PubMed ID: 3777533 [TBL] [Abstract][Full Text] [Related]